InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Thursday, 08/04/2022 7:45:13 PM

Thursday, August 04, 2022 7:45:13 PM

Post# of 426487
Amarin's Marine patents for very high trigs were invalidated by Judge Du...Generics are now capitalizing on this invalidation by the court by infringing on Amarin's R-IT patents and selling Vascepa for the CVD indication...Could they use the same strategy if the FDA approves Vascepa for the Alzheimer's indication?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News